New Cancer Test Could Save Patients From Diagnostic Surgeries, University of Pittsburgh Study

Published: Oct 21, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ThyroSeq, a new way of genetically testing thyroid nodules for cancer, could save patients an extra procedure. Developed at the University of Pittsburgh, ThyroSeq is a genetic sequencing test that allows researchers to accurately diagnose a thyroid growth for cancer. Dr. Yuri Nikiforov, director of thyroid molecular diagnostics at the Pitt School of Medicine, said thyroid nodules typically appear as a lump on the neck close to the “Adam’s apple.” He said they are more common in women and the elderly.

Hey, check out all the engineering jobs. Post your resume today!

Back to news